Furthermore, we found that the A/A genotype is associated with reduced recurrence-free survival after prostatectomy in prostate cancer patients (P<0.05; Supplementary Fig. 7a,b), consistent with an impact on CDH1 expression during tumour progression. Here, CDH1 is linked to Familial prostate cancer.